179 related articles for article (PubMed ID: 9827472)
1. [Improved coronary vasodilator capacity by drug lipid lowering therapy in patients in the early stage of coronary atherosclerosis with reduced coronary reserves and moderate LDL hypercholesteremia].
Baller D; Gleichmann U; Notohamiprodjo G; Weise R; Holzinger J; Montanus H; Betker S; Lehmann J
Z Kardiol; 1998; 87 Suppl 2():136-44. PubMed ID: 9827472
[TBL] [Abstract][Full Text] [Related]
2. Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis.
Baller D; Notohamiprodjo G; Gleichmann U; Holzinger J; Weise R; Lehmann J
Circulation; 1999 Jun; 99(22):2871-5. PubMed ID: 10359730
[TBL] [Abstract][Full Text] [Related]
3. Improvement of impaired myocardial vasodilatation due to diffuse coronary atherosclerosis in hypercholesterolemics after lipid-lowering therapy.
Yokoyama I; Momomura S; Ohtake T; Yonekura K; Yang W; Kobayakawa N; Aoyagi T; Sugiura S; Yamada N; Ohtomo K; Sasaki Y; Omata M; Yazaki Y
Circulation; 1999 Jul; 100(2):117-22. PubMed ID: 10402439
[TBL] [Abstract][Full Text] [Related]
4. Effects of short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reverse.
Huggins GS; Pasternak RC; Alpert NM; Fischman AJ; Gewirtz H
Circulation; 1998 Sep; 98(13):1291-6. PubMed ID: 9751677
[TBL] [Abstract][Full Text] [Related]
5. [Lipid intervention and coronary heart disease in men less than 56 years of age. The Coronary Intervention Study: CIS].
Rensing UF; Bestehorn HP; Roskamm H; Petersen J; Betz P; Spinder M; Benesch L; Schemeitat K; Blümchen G; Claus J; Wieland H; Böcker JF; Neiss A; Stiepel E; Mathes P; Kappenberger L; Braunagel K; Peters K; Meister G; Samek L; Schuon J; Leimenstoll B; Kiefer H
Z Kardiol; 1999 Apr; 88(4):270-82. PubMed ID: 10408031
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of atorvastatin on myocardial regions with initially low vasodilatory capacity at various stages of coronary artery disease.
Wielepp P; Baller D; Gleichmann U; Pulawski E; Horstkotte D; Burchert W
Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1371-7. PubMed ID: 16133398
[TBL] [Abstract][Full Text] [Related]
7. Improved coronary vasodilatatory capacity by H.E.L.P. apheresis: comparing initial and chronic treatment.
Mellwig KP; van Buuren F; Schmidt HK; Wielepp P; Burchert W; Horstkotte D
Ther Apher Dial; 2006 Dec; 10(6):510-7. PubMed ID: 17199883
[TBL] [Abstract][Full Text] [Related]
8. [Myocardial perfusion under H.E.L.P. -apheresis. Objectification by PET].
Mellwig KP; Baller D; Schmidt HK; V Buuren F; Wielepp JP; Burchert W; Horstkotte D
Z Kardiol; 2003; 92(Suppl 3):III30-7. PubMed ID: 14663599
[TBL] [Abstract][Full Text] [Related]
9. Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification.
Gould KL; Ornish D; Scherwitz L; Brown S; Edens RP; Hess MJ; Mullani N; Bolomey L; Dobbs F; Armstrong WT
JAMA; 1995 Sep; 274(11):894-901. PubMed ID: 7674504
[TBL] [Abstract][Full Text] [Related]
10. Additional benefit of vitamin E supplementation to simvastatin therapy on vasoreactivity of the brachial artery of hypercholesterolemic men.
Neunteufl T; Kostner K; Katzenschlager R; Zehetgruber M; Maurer G; Weidinger F
J Am Coll Cardiol; 1998 Sep; 32(3):711-6. PubMed ID: 9741516
[TBL] [Abstract][Full Text] [Related]
11. Effect of cholesterol lowering treatment on positive exercise tests in patients with hypercholesterolaemia and normal coronary angiograms.
Mansur AP; Serrano CV; Nicolau JC; César LA; Ramires JA
Heart; 1999 Dec; 82(6):689-93. PubMed ID: 10573494
[TBL] [Abstract][Full Text] [Related]
12. Long-term effect of simvastatin on the improvement of impaired myocardial flow reserve in patients with familial hypercholesterolemia without gender variance.
Yokoyama I; Yonekura K; Inoue Y; Ohtomo K; Nagai R
J Nucl Cardiol; 2001; 8(4):445-51. PubMed ID: 11481566
[TBL] [Abstract][Full Text] [Related]
13. Effect of short-term cardiovascular conditioning and low-fat diet on myocardial blood flow and flow reserve.
Czernin J; Barnard RJ; Sun KT; Krivokapich J; Nitzsche E; Dorsey D; Phelps ME; Schelbert HR
Circulation; 1995 Jul; 92(2):197-204. PubMed ID: 7600651
[TBL] [Abstract][Full Text] [Related]
14. Low density lipoprotein apheresis improves regional myocardial perfusion in patients with hypercholesterolemia and extensive coronary artery disease. LDL-Apheresis Atherosclerosis Regression Study (LAARS).
Aengevaeren WR; Kroon AA; Stalenhoef AF; Uijen GJ; van der Werf T
J Am Coll Cardiol; 1996 Dec; 28(7):1696-704. PubMed ID: 8962554
[TBL] [Abstract][Full Text] [Related]
15. Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy. A study with positron emission tomography.
Choudhury L; Rosen SD; Patel D; Nihoyannopoulos P; Camici PG
Eur Heart J; 1997 Jan; 18(1):108-16. PubMed ID: 9049522
[TBL] [Abstract][Full Text] [Related]
16. Coronary flow reserve is impaired in young men with familial hypercholesterolemia.
Pitkänen OP; Raitakari OT; Niinikoski H; Nuutila P; Iida H; Voipio-Pulkki LM; Härkönen R; Wegelius U; Rönnemaa T; Viikari J; Knuuti J
J Am Coll Cardiol; 1996 Dec; 28(7):1705-11. PubMed ID: 8962555
[TBL] [Abstract][Full Text] [Related]
17. A randomized, open-label, comparative study of simvastatin plus diet versus diet alone on angiographic retardation of coronary atherosclerosis in adult Japanese patients: Japanese utilization of simvastatin therapy (JUST) study.
Mizuno K; Nakamura H; Ohashi Y; Kaburagi T; Kitabatake A; Tochihara T; Hosoda S;
Clin Ther; 2004 Jun; 26(6):878-88. PubMed ID: 15262458
[TBL] [Abstract][Full Text] [Related]
18. Benefits of lipid-lowering therapy in men with elevated apolipoprotein B are not confined to those with very high low density lipoprotein cholesterol.
Stewart BF; Brown BG; Zhao XQ; Hillger LA; Sniderman AD; Dowdy A; Fisher LD; Albers JJ
J Am Coll Cardiol; 1994 Mar; 23(4):899-906. PubMed ID: 8106695
[TBL] [Abstract][Full Text] [Related]
19. Effect of simvastatin on coronary flow reserve in patients with atherosclerosis and hypercholesterolemia: an intracoronary Doppler study.
Jensen LO; Thayssen P; Pedersen KE; Haghfelt T
Coron Artery Dis; 2006 Feb; 17(1):51-6. PubMed ID: 16374142
[TBL] [Abstract][Full Text] [Related]
20. Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease.
Sdringola S; Nakagawa K; Nakagawa Y; Yusuf SW; Boccalandro F; Mullani N; Haynie M; Hess MJ; Gould KL
J Am Coll Cardiol; 2003 Jan; 41(2):263-72. PubMed ID: 12535820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
